Responses
Clinical pharmacy and clinical trials (including case series)
CPC-012 An Italian Cost-Effectiveness Analysis of Paclitaxel Albumin (Nab-Paclitaxel) Vs. Conventional Paclitaxel For Metastatic Breast Cancer Patients: The COSTANZA Study
Compose a Response to This Article
Other responses
No responses have been published for this article.